Hematology and Oncology

EmailEmail    |   Bookmark Page Bookmark  |   RSS Feeds RSS  |   Print Page Print  

Mary Eapen, MD, MSMary Eapen, MD, MS

Professor of Medicine

Mary Eapen, MD, MS, is Professor at the Medical College of Wisconsin and Senior Scientific Director - Research, Center for International Blood and Marrow Transplant Research.  Her research focuses on the use of graft sources other than bone marrow for allogeneic hematopoietic cell transplantation for acute leukemia and marrow failure disorders. 

Dr. Eapen received her MBBS from Ahmadu Bello University, Zaria, Nigeria, in 1987. She completed a pediatric residency in 1997. In 2000, Dr. Eapen completed a fellowship in hematology/oncology/blood and bone marrow transplant and a MS in Clinical Research at the University of Minnesota, Minneapolis, Minnesota.

Selected peer‐reviewed publications: (from 84 peer-reviewed publications)

  1. Eapen M, Klein JP, Ruggeri A, Spellman S, Lee SJ, Anasetti C, Arcese W, Barker JN, Baxter-Lowe LA, Fernandez-Vina MA, Freeman J, He V, Iori AP, Horowitz MM, Locatelli F, Marino S, Maiers M, Michel G, Sanz GF, Gluckman E, Rocha V.  Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy.  Blood. 2013. Oct 18 [Epub ahead of print]
  2. de Lima M, McNiece I, Robinson SN, Munsell M, Eapen M, Horowitz M, Alousi A, Saliba R, McMannis JD, Kaur I, et al. Cord blood engraftment with ex vivo mesenchymal-cell coculture.  N Engl J Med. 2012; 367: 2301 – 2315
  3. Eapen M, Klein JP, Sanz GF, Spellman S, Ruggeri A, Anasetti C, Brown M, Champlin RE, Gracia-Lopez J, Hattersley G, Koegler G, Laughlin MJ, Michel G, Nabhan SK, Smith FO, Horowitz MM, Gluckman E, Rocha V.  Effect of donor-recipient matching at HLA A, B, C and DRB1 on outcomes after umbilical cord blood transplantation for leukemia and myelodysplastic syndrome: a retrospective analysis.  Lancet Oncol. 2011; 12: 1214-1221
  4. Eapen M, Le Rademacher J, Antin JH, Champlin RE, Carreras J, Fay J, Passweg JR, Tolar J, Horowitz MM, Marsh JC, Deeg HJ. Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia.  Blood. 2011; 118: 2618-2621
  5. Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W, Sirvent A, Chaomplin RE, Chao N, Gee AP, Isola L, Laughlin MJ, Marks DI, Nabhan S, Soiffer R, Horowitz MM, Gluckman E, Wagner JE.  Effect of graft source on unrelated donor haematopoietic stem cell transplantation in adults with acute leukemia: a retrospective analysis.  Lancet Oncol. 2010; 11: 653 – 660
  6. Eapen M, Rubinstein P, Zhang M‐J, Stevens C, Kurtzberg J, Scaradavou A, Loberiza FR, Champlin RE, Horowitz MM and Wagner JE.  Comparison of outcomes after transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia. Lancet. 2007; 369: 1947‐1954
© 2014 Medical College of Wisconsin
Page Updated 11/04/2014